ӳ����ý

Behind an invisible curtain of light, robotic pods suspend drops of liquid in tiny plastic cones and deliver crucial chemicals to DNA destined for analysis. This automated dance takes place in the Biomek FX, a key piece of equipment in the ӳ����ý's Genetic Analysis Platform (GAP) laboratory, where members of the Whole Genome Team prepare samples of genetic material for genotyping. The machine is an automatic pipettor, transferring liquids to samples during chemistry steps making work much easier for research technicians Mike DaSilva, Ryan McGinty, and Teni Minnetyan.

Last week, researchers at the ӳ����ý announced exciting study results that reveal how cancer cells can evade treatment and become resistant. They found that although anti-melanoma drugs can block the B-RAF gene that drives these cancers, malignant melanoma cells can “turn on” another gene called COT and survive, pointing to this gene as another potential target for therapy.